References

  1. Vauloup-Fellous C. Infections virales chez le nouveau-né. Revue Francophone des Laboratoires. 2018; 2018(500):48-54. Google Scholar

  2. Sbiti M, Lahmadi K, Louzi L. Rubella immune status in pregnant women in central Morocco. JSM Microbiology. 2017;5:1041. Google Scholar

  3. Belefquih B1, Kasouati J, Doblali T, Touil N, Tagajdid MR, Kabbaj H et al. Rubella seroprevalence in pregnant women at the military teaching hospital, Rabat, Morocco. Int J Gynecol Obstet. 2013 Feb;120(2):191-2. PubMed | Google Scholar

  4. Hannachi N, Marzouk M, Harrabi I, Ferjani A, Ksouri Z, Ghannem H et al. Séroépidémiologie de la rubéole, de la varicelle et des infections par le cytomégalovirus et le parvovirus B19 chez les femmes enceintes dans la région de Sousse, Tunisie. Bull Soc Pathol Exot. 2011 Feb;104(1):62-7. PubMed | Google Scholar

  5. Gilbert NL, Rotondo J, Shapiro J, Sherrard L, Fraser WD, Ward BJ. Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada. Vaccine. 2017 May 25;35(23):3050-3055. PubMed | Google Scholar

  6. Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B et al. Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010. Int J Infect Dis. 2016 Aug;49:196-201. PubMed | Google Scholar

  7. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X et al. Rubella virus immunization status in preconception period among Chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017 May 25;35(23):3076-3081. PubMed | Google Scholar

  8. Moura AA, Gonçalves de Mello MJ, Correia JB. Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign. Vaccine. 2016 Jan 20;34(4):445-450. PubMed | Google Scholar

  9. Vilajeliua A, Garcia-Basteiro AL, Valencia S, Barreales S, Oliveras L, Calvente V et al. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine. 2015 Apr 8;33(15):1767-72. PubMed | Google Scholar

  10. Regine B, Kirsti V, Samdal HH, Nordbø SA, Nøkleby H, Dudman SG. Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014 May;86(5):820-6. PubMed | Google Scholar

  11. Mounerou S, maléwé K, Anoumou YD, Sami N, Koffi A, Mireille PD. Seroprevalence of rubella IgG antibody among pregnant women attending antenatal clinic in Lomé, Togo. Am J Infect Dis Microbiol. 2015;3(4):134-136. Google Scholar

  12. Guillet M. Rubéole congénitale en 2010 et vaccination. Antibiotiques. 2010;12(3):171-180. Google Scholar

  13. Organisation Mondiale de la Santé (OMS). Relevé épidémiologique hebdomadaire Progrès réalisés pour combattre et éliminer la rubéole et le syndrome de rubéole congénitale dans le monde 2000-2016 N° 17. Novembre 2017;92:701-716. Google Scholar

  14. Doret M, Marcellinc L. Les vaccinations dans le post-partum immédiat: recommandations. J Gynecol Obstet Biol Reprod. 2015;44(10):1135-1140. PubMed | Google Scholar